The organosulfur compound ajoene, a constitutent of garlic, has been shown to induce apoptosis in a leukemic cell line as well as in blood cells of a leukemic patient. The mechanisms of action of ajoene, however, are unknown. The present study aims to characterize the molecular events leading to ajoenetriggered apoptosis. We show here that ajoene (20 M) leads to a time-dependent activation of caspase-3-like activity as well as to the proteolytic processing of procaspase-3 and -8. Activation of caspases was necessary for ajoene-induced apoptosis since the broad-range caspase inhibitor zVAD-fmk completely abrogated ajoene-mediated DNA fragmentation. Although the initiator caspase-8 was activated, the CD95 death receptor was not involved in death signaling since the HL-60 clone used was shown to express a functionally inactive CD95 receptor. Furthermore, ajoene induced the release of cytochrome c, which was not inhibited by zVAD-fmk indicating that cytochrome c release precedes caspase activation. Ajoene also led to a dissipation of the mitochondrial transmembrane potential. Overexpression of Bcl-x L clearly diminished ajoeneinduced caspase activation as well as apoptosis. These results indicate that apoptosis in leukemia cells triggered by ajoene is based on the activation of a mitochondria-dependent caspase cascade which includes also the activation of the initiator caspase-8. Leukemia (2002) 16, 74-83.
Introduction
Organosulfur compounds (OSC) from natural sources (eg garlic, onion, broccoli) as well as related synthetic compounds have been shown to possess anticarcinogenic activity. [1] [2] [3] [4] The mechanism discussed to mediate the chemopreventive effect of OSC is an increase in the activity of phase II detoxication enzymes. [1] [2] [3] [4] On the other hand, OSC were also demonstrated to have direct antiproliferative effects on tumor cells. [5] [6] [7] Importantly, several reports demonstrated triggering of apoptosis by diverse OSC in leukemia cells. [8] [9] [10] [11] Wong et al 11 studied the structural requirements of synthetic OSC to induce apoptosis in human leukemia cells. They found that a disulfide moiety seems to be necessary to trigger cell death whereas adjacent groups contribute to the specificity of cell killing.
Studies from our own group demonstrated that ajoene, an allylic disulfide originally isolated from garlic extracts, 12 induces apoptosis in the human acute myeloid leukemia cell line HL-60 as well as in peripheral blood mononuclear cells (PBMC) isolated from a patient with a chronic myelogenous leukemia undergoing a myeloid blast crisis. In contrast, quiescent as well as proliferating PBMCs isolated from healthy donors remained unaffected. Thus, evidence is provided that certain OSC may have antileukemic potential. The molecular pathway, however, by which OSC trigger apoptosis, needs to be clarified.
Two major pathways mediating drug-induced apoptosis have been characterized. One involves the triggering of cell surface death receptors and the other targets mitochondria without the involvement of a receptor/ligand system. 13 In certain cell types, the CD95 (APO-1/Fas) receptor system was suggested to be involved in apoptosis evoked by chemotherapeutic drugs. Drug-mediated activation of the CD95 signaling pathway was shown to occur by induction of the CD95 ligand (CD95-L) or increased expression of the CD95 receptor. [14] [15] [16] [17] CD95 is a cell surface receptor belonging to the TNF/nerve growth factor-receptor superfamily. Activation of this receptor leads to trimerization and subsequent recruitment of FADD (Fas-associated protein with death domain) and procaspase-8 forming a death-inducing signaling complex (DISC). 18 Depending on the cell type, either large amounts of procaspase-8 are activated directly at the DISC leading to the activation of a caspase cascade independent of mitochondria (type I cells) or small amounts of activated caspase-8 lead to a pathway which needs to be amplified by a mitochondriacontrolled caspase cascade (type II cells). 19 Besides the view that chemotherapeutic drugs act through triggering the CD95 receptor/ligand system, there are also studies demonstrating that anticancer drug-induced apoptosis occurs in the absence of a functional CD95 receptor/ligand system. [20] [21] [22] [23] These apoptotic signals seem to be integrated by mitochondria leading to a pathway involving a caspase cascade downstream of these organelles. A central event in mitochondria-controlled cell death is the mitochondrial membrane permeabilization (MMP). MMP of the inner mitochondrial membrane causes loss of the mitochondrial transmembrane potential (⌬⌿ m ). MMP of the outer membrane leads to the release of apoptogenic factors such as cytochrome c into the cytosol. Released cytochrome c binds Apaf-1 forming a complex which in turn recruits and subsequently activates procaspase-9. Activated caspase-9 is released from the complex to cleave and activate effector caspases, eg caspase-3. Important regulators of cytochrome c release and therefore of mitochondria-mediated caspase activation are members of the Bcl-2 family proteins. Overexpression of Bcl-2 or Bcl-x L were shown to block cytochrome c release in response to various apoptotic stimuli. 24, 25 To date, the molecular pathways leading to OSC-triggered apoptosis in leukemia cells remain unknown. The OSC ajoene is a promising experimental anti-leukemic agent since it selectively induces apoptosis in human promyeloleukemic cells. 9 Therefore, the aim of the present study was to characterize the molecular signaling involved in ajoene-induced cell death.
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Materials and methods
Cells and culture conditions
The human acute myeloid leukemia cell line HL-60 (DSM ACC 3; DSMZ, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany) was cultured (37°C and 5% CO 2 ) in RPMI 1640 medium supplemented with 10% fetal bovine serum and L-glutamine (2 mM) (Life Technologies, Eggenstein, Germany). HL-60 transfected with the pSFFVneobcl-x L plasmid (HL-60/bcl-x L ) or pSFFV-neo plasmid (HL-60/neo) (a gift from Dr KN Bhalla, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA) 26 was cultivated as described for HL-60 cells except that 0.1 mM non-essential amino acids and 1 mM sodium pyruvate (Life Technologies) were added to the culture medium. One mg/ml G 418 (Life Technologies) was added every fifth passage. Cells exposed to G418 were not used for experiments. The Jurkat clone J16, Jurkat R cells 27 and Jurkat T cells transfected with vector control or bcl-x L 28 (kindly provided by Drs PH Krammer and H Walczak, DKFZ, Heidelberg, Germany) were cultured as described. 29 Ajoene ((E,Z)-4,5,9-trithiadodeca-1,6,11-triene-9-oxide) was obtained from Lichtwer Pharma (Berlin, Germany) and dissolved in PBS. N-acetylcysteine (NAC) was obtained from Sigma (Deisenhofen, Germany), dissolved in PBS and the pH adjusted to pH 7.4.
Quantification of apoptosis
Quantification of apoptosis was performed by flow cytometric analysis of propidium iodide-stained nuclei using CELLQuest software (Becton Dickinson, Heidelberg, Germany) according to Nicoletti et al. 30 Briefly, cells were incubated for 12 h in a hypotonic buffer, containing 1% sodium citrate, 0.1% Triton-X-100, and 50 g/ml propidium iodide, in order to lyse cells and stain nuclei, which were analyzed by flow cytometry. Nuclei to the left of the 'G1-peak' containing hypodiploid DNA were considered apoptotic. Susceptibility of HL-60 cells towards CD95-mediated apoptosis was examined using soluble recombinant CD95-L (330 ng/ml; Alexis, Grü nberg, Germany). To examine whether apoptosis is dependent on caspase activation, cells were preincubated with the pan-caspase inhibitor zVAD-fmk or the caspase-8 inhibitor zIETD-fmk (both from Calbiochem, Bad Soden, Germany) for 1 h. Apoptosis was quantified as described above.
Analysis of caspase-3-like activity
Cells were seeded in 24-well plates (4 × 10 5 /ml), stimulated with ajoene (20 M) or etoposide (10 g/ml) for different periods of time (0-22 h). Cells were collected by centrifugation, washed with ice-cold PBS and lysed in 5 mM MgCl 2 , 1 mM EGTA, 0.1% Triton X-100, 25 mM Hepes pH 7.5 supplemented with 1 g/ml aprotinin, leupeptin, pepstatin and 1 mM pefabloc (Roche, Mannheim, Germany) by four cycles of freeze-thawing. Lysates were stored at −70°C until further analysis. Cytosols were prepared by centrifugation at 14 000 g (15 min, 4°C) and transferred to 96-well microtiter plates (Greiner, Nü rtingen, Germany). The fluorometric DEVD-afc cleavage assay was carried out according to the method described by Thornberry. 31 Cytosolic extracts (10 l, approximately 1 mg/ml protein) or recombinant caspase-3 (10 l, 30 ng/ml protein) were diluted 1:10 with substrate buffer (55 M Leukemia fluorogenic substrate DEVD-afc in 50 mM Hepes, pH 7.4, 1% sucrose, 0.1% CHAPS, 10 mM DTT). Blanks contained 10 l extraction buffer and 90 l substrate buffer. Generation of free 7-amino-4-trifluoromethylcoumarin (afc) at 37°C was determined by fluorescence measurement at t = 0/t = 30 min using the fluorometer plate reader Victor 2 (Wallac Instruments, Turku, Finland) set at an excitation wavelength of 385 nm and an emission wavelength of 505 nm. Protein concentrations of the corresponding samples were estimated with the PierceAssay (Pierce, Rockford, IL, USA) and the activity was calculated using serially diluted standards (0-5 M afc). Control experiments confirmed that the activity was linear with time and with protein concentration under the conditions described above.
Expression of the CD95 receptor
Cells were seeded (1 × 10 6 /ml) in a 24-well plate. To detect CD95 surface expression by flow cytometry cells were incubated at 4°C for 30 min with mouse anti-CD95 antibody (clone ZB4, 10 g/ml; MBL, Nagoya, Japan) or the isotype control (mouse IgG 1 ; Pharmingen, Becton Dickinson, Heidelberg, Germany). After washing the cells twice with phosphatebuffered saline containing 1% fetal calf serum (PBS/1% FCS), cells were incubated at 4°C for 30 min with fluorescein isothiocyanate (FITC)-conjugated rat anti-mouse IgG 1 (Pharmingen, Becton Dickinson). Cells were washed again (2 × PBS/1% FCS) and analyzed by a FACSCalibur flow cytometer (Becton Dickinson).
Analysis of mitochondrial transmembrane potential (⌬⌿)
HL-60 were treated with ajoene (20 M) for various time periods (0-24 h) and stained with the fluorochrome 5,5Ј,6-6'tetrachloro-1,1Ј,3,3Ј-tetraethylbenzimidazolcarbocyanine iodide (JC-1; 1,25 M). After incubation at 37°C for 20 min in the dark, the membrane potential was measured by flow cytometry (FACSCalibur; Becton Dickinson). JC-1 aggregates were detected at 625 nm (red fluorescence, FL-2), monomers at 534 nm (green fluorescence, FL-1). JC-1 (Molecular Probes, Eugene, OR, USA) was dissolved in dimethylformamide (5 mg/ml) and further diluted in 70% ethanol. For fluorescence microscopy cells were treated as described above and pictures were taken on a CLSM 510 microscope with a LSM 510 software (Zeiss, Jena, Germany).
Immunoblot analysis
Cells (1 × 10 6 /ml) were incubated in the absence or presence of ajoene (20 M) for various time periods (0-24 h), collected by centrifugation, washed with ice-cold PBS and lysed immediately in 1% Triton X-100, 0.15 M NaCl and 10 mM Tris-HCl pH 7.4 supplemented with the protease inhibitor complete (Roche, Mannheim, Germany) for 30 min at 4°C. Lysates were homogenized through a 22-G needle and centrifuged at 10 000 g for 10 min at 4°C. The supernatants were collected and protein was measured by the method according to Bradford. 32 Cell lysates, containing equal amounts of protein, were boiled in SDS-sample buffer for 5 min before running on a SDS-polyacrylamide gel (10% for PARP, caspase-8, Bcl-x L , 15% for caspase-3, cytochrome c). Proteins were transferred to polyvinylidene difluoride membranes (Immobilon-P, Millipore, Eschborn, Germany). Membranes were blocked with 5% fat-free dry milk in TBS-T pH 8.0 (Trisbuffered saline (50 mM Tris, pH 8.0, 150 mM NaCl) with 0.1% Tween 20) and then incubated with specific antibodies against caspase-8 (mouse monoclonal antibody C-15, 1:5 dilution of hybridoma supernatant, 33 kindly provided by Prof PH Krammer), caspase-3 (mouse monoclonal antibody, clone 19, Transduction Laboratories, Becton Dickinson, Heidelberg, Germany), cytochrome c (mouse monoclonal antibody 7H8.2C12, Pharmingen, Becton Dickinson), PARP (mouse monoclonal antibody Ab-2, Calbiochem-Novabiochem, Bad Soden, Germany) or Bcl-x S/L (rabbit polyclonal antibody S-18; Santa Cruz Biotechnology, Heidelberg, Germany) overnight at 4°C. After washing three times with TBS-T, specific proteins were visualized by secondary antibody-horseradish peroxidase conjugates and the chemiluminiscence reagent Renaissance Plus (NEN Life Science Products, Zaventem, Belgium). Chemiluminiscence was detected on a Kodak Digital Science Image station 440CF (NEN Life Science Products, Zaventem, Belgium).
Measurement of cytochrome c release
HL-60 cells (3 × 10 6 ) seeded in 24-well plates were treated with 20 M ajoene for the indicated time. Cells were harvested by centrifugation (300 g). Release of cytochrome c from mitochondria was analyzed according to Leist et al. 34 Briefly, pellets were resuspended in permeabilization buffer (210 mM D-mannitol, 70 mM sucrose, 10 mM HEPES, 5 mM succinate, 0.2 mM Na-EGTA, 0.15% BSA, 80 g/ml digitonin, pH 7.2) and gently shaken at 4°C for 20 min. Permeabilized cells were centrifuged (300 g), the supernatant removed and centrifuged again (10 min, 13 000 g). The obtained cytosol was separated on a 15% SDS-PAGE and probed for cytochrome c as described above. The remaining pellet of permeabilized cells was lysed in 0.1% Triton/PBS (15 min, 4°C, 5× ultrasonic treatment), centrifuged (12 000 g, 4°C, 10 min) and the supernatant containing cytochrome c from mitochondria analyzed by SDS-PAGE. Protein was quantified according to Bradford. 32 
Quantification of reactive oxygen species (ROS)
Peroxide production in HL-60 cells was quantified as described previously. 9 
Statistical analysis
All experiments were performed at least three times. Results are expressed as mean value ± s.e.m. Statistical comparisons were made by ANOVA followed by a Dunnett or Bonferroni's multiple comparisons test or by an unpaired two-tailed Student's t-test. P values Ͻ0.05 were considered significant.
Results
Ajoene-induced apoptosis is dependent on activation of caspases
As reported previously, ajoene was shown to induce apoptosis in promyeloleukemic cells as judged by cell morphology, the formation of sub-diploid DNA as well as DNA fragmentation detected by gel electrophoresis. 9 In this study, initially, the time dependency (1-24 h) of ajoene (20 M)-induced cell death was confirmed. Figure 1a shows that significant apoptosis is detected as early as 5 h after ajoene treatment. In order to characterize the molecular events involved in ajoeneinduced apoptosis, we first examined whether caspases are activated upon ajoene treatment. As measured by the fluorometric DEVD-cleavage assay caspase-3-like activity was detectable at 4 h and significantly increased 8 h after cell exposure to ajoene (Figure 1b) . Time-dependent activation of caspase-3-like proteases was confirmed by monitoring cleavage of poly(ADP-ribose)polymerase (PARP). The 116-kDa protein PARP, a nuclear protein involved in DNA repair, is specifically cleaved by caspases during apoptosis. 35 The Western blot in Figure 1c shows the appearance of the characteristic 85-kDa fragment in the time course of ajoene treatment. In accordance with the results obtained with the fluorometric DEVD-cleavage assay, processed PARP was detected 8 h after cell exposure to ajoene. Importantly, pretreatment of cells with the broad-spectrum caspase inhibitor zVAD-fmk completely abrogated DNA fragmentation indicating that activation of caspases is necessary for ajoene-triggered apoptosis (Figure 1d ).
To further specify the involved caspases, we monitored the processing of the effector caspase-3 and initiator caspase-8 by immunoblot analysis using specific antibodies against the individual active proteases. Treatment of HL-60 cells with ajoene (1-24 h) resulted in the proteolytic cleavage of caspase-3 to the active p17 subunit. As shown in Figure 2a , p17 was detectable as early as 4 h culminating at 5 to 8 hours, indicating that the effector caspase-3 is activated during ajoene-induced apoptosis. Caspase-8 is expressed as inactive precursor in two isoforms, caspase-8/a and caspase-8/b, which appear as two protein bands of 55 and 53 kDa. 33 Upon activation, caspase-8 is cleaved to the p43 and p41 intermediates, which are further processed to the active subunit p18. Figure 2b shows the time-dependent appearance of the p41 and p43 intermediates after ajoene treatment. Interestingly, caspase-8 cleavage occurred concomitantly with processing of caspase-3 (Figure 2a and b) . These results demonstrate that caspase-3 and caspase-8 are involved in ajoene-induced apoptotic signaling.
Ajoene-induced apoptosis occurs independently of the CD95 receptor system
The initiator caspase-8 was shown to be recruited and activated upon engagement of the CD95 (APO-1/Fas) receptor leading to the activation of a downstream caspase pathway. 36 We, therefore, examined whether ajoene-mediated apoptosis in HL-60 cells might involve the CD95/CD95-L system. Although HL-60 cells were reported to express high levels of CD95 receptor and to possess a functional CD95/CD95-L signaling system, 37, 38 we first checked whether this is also the case for the HL-60 clone used in the present study. Expression of CD95 receptor protein was assessed by immunofluorescence flow cytometry. As shown in Figure 3a , HL-60 cells indeed expressed considerable levels of CD95 receptor. Comparing published data on HL-60 cells it is evident that the susceptibility of these cells towards CD95-mediated apoptosis varies.
37-39 Therefore, we analyzed whether soluble CD95-L is able to induce apoptosis in the used HL-60 clone. Interestingly, HL-60 cells did not undergo apoptosis upon stimulation with soluble CD95-L, even if high concentrations were used. In contrast, CD95-L at the same or much lower concentrations was confirmed to induce apoptosis in Jurkat T cells (data not shown). Figure 3b shows the percent of apoptotic cells obtained after treatment with ajoene (20 M) and soluble CD95-L (330 ng/ml). Whereas ajoene-induced apoptosis was highly significant after 6 as well as 24 h, soluble CD95-L did not induce apoptosis at all, suggesting that the HL-60 clone used here has no functionally active CD95 system. Although the used HL-60 clone did not respond to soluble CD95-L ajoene might sensitize HL-60 cells towards the CD95 receptor system. We therefore preincubated HL-60 cells with ajoene (20 M) for 1 h and treated cells with soluble CD95-L (330 ng/ml). The apoptotic response after ajoene/CD95-L treatment was not significantly different to the treatment with ajoene alone (data not shown), making it unlikely that ajoene sensitizes HL-60 cells towards the CD95 receptor. The initiator caspase-8 is essential for the apoptotic response downstream of the CD95 receptor. We, therefore, investigated whether caspase-8 is essential for ajoene-mediated apoptosis. We preincubated cells with the caspase-8 inhibitor zIETD-fmk at concentrations (10 and 50 M) that were confirmed to block CD95-L-induced apoptosis in Jurkat T cells effectively (data not shown). As shown in Figure 3c , neither of these concentrations was able to block or even reduce ajoene-mediated apoptosis significantly. Together these experiments suggest that ajoene-mediated apoptosis occurs independently of the CD95 receptor system.
Ajoene induces mitochondrial membrane permeabilization (MPP)
Many apoptotic signals acting independently of a receptor/ligand system use primarily mitochondria to trans- duce their death-inducing message. Mitochondrial membrane permeabilization (MMP) affecting the outer and/or inner membrane is a key event in mitochondria-controlled cell death. 24, 40, 41 Outer membrane permeabilization involves the release of proteins, such as cytochrome c, which are normally confined to the intermembrane space. Inner membrane permeabilization is indicated by a dissipation of the electrochemical gradient (⌬⌿) created by the proteins of the respiratory chain located on the inner mitochondrial membrane.
We therefore examined whether ajoene treatment leads to outer and/or inner MMP of HL-60 cells. Figure 4a shows the time-dependent release of cytochrome c into the cytosol upon exposure to ajoene (20 M). Significant increased levels of cytochrome c in the cytosol were detectable as early as 4 h after ajoene treatment indicating that outer MMP is an early event in ajoene-induced apoptosis which seems to precede caspase activation. Indeed, the broad-range caspase-inhibitor zVAD-fmk was unable to block cytochrome c release ( Figure  4a , lower panel) providing evidence that outer MMP occurs independent of caspases.
Involvement of inner membrane permeabilization was assessed indirectly by determining a reduction in ⌬⌿ m by incubating cells with the fluorochrome JC-1 which forms aggregates (red) or monomers (green) depending on ⌬⌿ m . Dissipation of ⌬⌿ m can be judged by flow cytometry measuring a decrease of FL-2 which correlates with an impaired formation of JC-1 aggregates. 42 As shown in Figure 4b 
Ajoene-mediated apoptosis and activation of caspases in Bcl-x L overexpressing HL-60 cells
Anti-apoptotic members of the Bcl-2 family, eg Bcl-2 and Bclx L , are able to prevent mitochondrial changes leading to apoptosis by 'guarding the mitochondrial gate'. 43 Overexpression of these proteins can block cytochrome c release and thereby the activation of caspases downstream of mitochondria. 25 Ajoene-induced caspase activation seemed to follow redistribution of cytochrome c suggesting that their activation might occur downstream of mitochondria. To provide evidence for this notion, ajoene was applied to HL-60 cells overexpressing Bcl-x L (HL-60/bcl-x L ; Figure 5a ). Doseresponse studies performed for 8 as well as 24 h showed that HL-60/bcl-x L cells underwent significant reduced apoptosis compared to control cells (HL-60/neo) (Figure 5b ). Caspase-3-like activity was considerably delayed in HL-60/bcl-x L cells compared to HL-60/neo cells. A significant activity was observed as late as 22 hours after ajoene treatment (Figure 5c ). Accordingly, processed caspase-3 in HL-60/bcl-x L appeared strongly delayed and was hardly detectable by immunoblot analysis. In contrast, in HL-60/neo cells p17 could be detected as early as 3 h after cell stimulation (Figure 5d ). Interestingly, ajoene completely failed to cleave caspase-8 in HL-60/bcl-x L cells whereas caspase-8 processing readily occurred in HL-60/neo cells (Figure 5e ). These data indicate that ajoene treatment leads to the activation of the effector caspase-3 as well as the initiator caspase-8 downstream of mitochondrial events in HL-60 cells (intrinsic pathway of apoptosis).
To address the question whether ajoene also induces in other leukemic cells an intrinsic pathway of apoptosis, Jurkat leukemia T cells, Jurkat R cells, a mutant that does not express a CD95 receptor 27 as well as Jurkat T cells transfected with a control vector or the bcl-x L gene 28 were exposed to ajoene. Ajoene induced apoptosis in Jurkat as well as in Jurkat R cells and Jurkat/bcl-x L cells showed a similar protection to ajoene as did HL-60/bcl-x L cells suggesting also an intrinsic pathway in Jurkat leukemia T cells. 
Leukemia
Ajoene-mediated generation of ROS occurs upstream of mitochondrial-dependent caspase activation
In our previous study we found that ajoene-induced apoptosis is accompanied by the generation of ROS and subsequent activation of the transcription factor NF-B. 9 Having identified an intrinsic pathway of apoptosis for ajoene the question arises whether generation of ROS/activation of NF-B is an initial event upstream of the mitochondrial-dependent caspase activation or whether ROS production occurs downstream of or simultaneously with other mitochondrial events.
Previous results demonstrated that increase of ROS and activation of NF-B are early events detected as early as 20 min and 1 h after activation with ajoene, respectively 9 (data not shown). Thus, ROS and activation of NF-B clearly precede mitochondrial events like cytochrome c release and loss of ⌬⌿ m . However, in order to provide more direct evidence that ROS/activation of NF-B lies upstream of mitochondria additional experiments were performed. Figure 6a shows that the antioxidant NAC that was demonstrated to inhibit ajoeneinduced ROS generation, NF-B activation as well as DNA fragmentation, 9 is able to reduce caspase-3 activation considerably, indicating that ROS lies upstream of mitochondrialdependent caspase-3 activation.
Furthermore, if ajoene-mediated ROS generation is a mitochondrial event HL-60 cells overexpressing Bcl-x L should be less sensitive towards ajoene. 24, 43 Figure 6b , however, demonstrates that there is no significant difference between HL-60/neo and HL-60/bcl-x L cells regarding their ROS response after ajoene exposure.
These data suggest that previously shown ROS production and subsequent activation of NF-B most likely lie upstream of mitochondrial-dependent caspase activation.
Discussion
Organosulfur compounds have been demonstrated to possess potential as anti-leukemic drugs since several OSC including ajoene have been shown to induce apoptosis in leukemia cells.
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The mechanism, however, by which these compounds trigger apoptosis is largely unknown.
The data presented here provide insight into the signaling pathway leading to ajoene-mediated apoptosis in the human promyeloic cell line HL-60. We demonstrated that ajoene led to the proteolytic processing of procaspases. Ajoene also induced caspase activity, as determined by the DEVD-afc cleavage assay and the proteolytic degradation of the caspase-3 substrate PARP. Activation of caspases was necessary for ajoene-mediated apoptotic cell death since DNA fragmentation was completely inhibited by the broad-spectrum caspase inhibitor zVAD-fmk. Caspases were activated as early as 5 h after cell exposure to ajoene. Interestingly, the initiator caspase-8 was processed concomitantly with the effector caspase-3.
Caspase-8 is well known to be activated upon CD95 receptor triggering. The enzyme is classified as initiator caspase containing the characteristic large prodomain with two death effector domains (DED). DEDs of caspase-8 and signaling adapter proteins such as FADD can interact and thus initiate death receptor-mediated apoptosis. 25, 44 Since exposure of cells to ajoene caused activation of caspase-8, a CD95-mediated pathway was initially presumed to be involved in ajoene-induced apoptosis. In fact, various other chemotherapeutic drugs have been shown to activate this death receptor pathway by upregulating CD95 and/or CD95-L expression. [14] [15] [16] [17] Unexpectedly, analysis of the HL-60 clone used in this study clearly demonstrated that although the cells express CD95 protein, the receptor could not be activated by its ligand (CD95-L), indicating that the HL-60 cells used do not possess a functional CD95 system. Although this finding rendered a participation of the CD95 receptor unlikely we investigated whether activation of the CD95-coupled initiator caspase-8 is necessary for ajoene-induced DNA fragmentation. Applying the caspase-8 inhibitor zIETD-fmk at concentrations that effectively block CD95-L-induced apoptosis in Jurkat T cells, the inhibitor was unable to inhibit ajoene-mediated apoptosis. The CD95 receptor system, thus, seemed not to be involved in ajoene-mediated apoptosis.
On the other hand, there are also non-receptor signal transduction pathways leading to the activation of caspases. Those signals seem to be integrated by mitochondria involving the release of mitochondrial factors such as cytochrome c into the cytosol. Released cytochrome c binds to the cytoplasmic protein Apaf-1 which then undergoes a nucleotide-dependent conformational change that allows binding and subsequent processing of procaspase-9. Active caspase-9 then leads to the processing of downstream caspases like caspase-3. 13, 25, 44 Redistribution of cytochrome c into the cytosol, indeed, occurred in response to ajoene. Elevated levels in the cytosol were detectable as early as 4 h after cell exposure to ajoene, indicating that cytochrome c release is an early event in the signaling cascade preceding caspase activation. Release of cytochrome c from the mitochondrial intermembrane space is connected to outer mitochondrial membrane permeabilization (MMP). Outer MMP is mostly but not always associated with loss of the mitochondrial transmembrane potential (⌬⌿ m ), which occurs as a consequence of inner MMP. 24 Measuring ⌬⌿ m we found that ajoene also induced inner MMP which occurred in a similar time-frame as outer MMP.
Further evidence for a central role of mitochondria in ajoene-induced apoptosis came from experiments with HL-60 cells overexpressing Bcl-x L . Overexpression of anti-apoptotic Bcl-2 or Bcl-x L was shown to prevent apoptotic mitochondrial events like cytochrome c release in response to a wide variety of stimuli. 25, 43 Indeed, Bcl-x L was found to strongly reduce ajoene-induced DNA fragmentation indicating that ajoenemediated apoptosis is dependent on the 'activation' of mitochondria.
Processing of the effector caspase-3 and the initiator caspase-8 occurred simultaneously, both succeeding cytochrome c release. This led us to assume that both caspases are activated downstream of mitochondria. Indeed, HL-60/bcl-x L cells showed significant delayed caspase-3-like activity as well as Leukemia caspase-3 processing. Moreover, Bcl-x L overexpression completely blocked proteolytic cleavage of caspase-8 giving clear evidence for a mitochondria-controlled caspase-3 as well as caspase-8 activation.
Processing of the apical procaspase-8 downstream of mitochondria was shown to require, besides caspase-9, caspase-3 and possibly caspase-6. 41, 45, 46 The similar time-frame of ajoene-mediated caspase-3 and caspase-8 processing, however, would favor a model in which both caspases are activated by a common preceding event, ie activation of procaspase-9. On the other hand, in HL-60/bcl-x L cells caspase-8 processing was completely blocked whereas activation of caspase-3 appeared to be reduced and strongly delayed. This argues for the possibilities that either caspase-8 indeed succeeds caspase-3 whose activation is too weak in HL-60/bclx L cells to further activate caspase-8, or caspase-8 is directly activated by a mitochondrial factor which is blocked by Bclx L . The latter possibility fits into a model which was proposed for the CD95 triggered apoptotic pathway in type II cells. 19 Further studies using specific caspase inhibitors will clarify this issue in ajoene-induced apoptosis.
In ajoene-mediated apoptosis caspase-3-like proteases, particularly caspase-3 and caspase-8, were demonstrated to be activated downstream of mitochondria. However, other caspases might be active in the signaling pathway from ajoene to mitochondria. In this respect, we showed, that the broadspectrum caspase inhibitor zVAD-fmk was not able to abrogate ajoene-induced cytochrome c release, suggesting that initial redistribution of cytochrome c is not mediated by caspases.
Previously shown data demonstrated that ajoene-induced apoptosis is accompanied by the release of ROS and the activation of the transcription factor NF-B. 9 This causes the question to arise of how these data are linked to the present results showing an ajoene-mediated intrinsic pathway of apoptosis. All data collected support the view that ROS/NF-B activation rather lies up-than downstream of mitochondria-dependent caspase activation. Particularly the finding that overexpression of Bcl-x L in HL-60 leads to an inhibition of caspases and DNA fragmentation but not to an inhibition of ROS production substantiates this view. An observation that also fits into this model is that inhibition of caspases, eg by zVAD-fmk or Bclx L overexpression, prevents ajoene-induced DNA fragmentation as a hallmark of apoptosis but does not totally prevent cell death (unpublished observation). This cell death may be due to reactive oxygen species that might activate alternative pathways when caspases are blocked. 47 In summary, we demonstrated that the apoptotic cell death induced by the OSC ajoene is fully dependent on the activation of caspases which are processed in response to apoptotic mitochondrial events. Signaling via the CD95 receptor as well as the activation of caspases upstream of mitochondria could be excluded. Further experiments will clarify whether ajoene directly affects mitochondria or whether ajoene causes mitochondrial permeabilization by an indirect fashion.
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